Common treatment can wake up dormant cancer cells, causing the disease to spread from original sites to other organs, team discovers.

This new article publication from Acta Pharmaceutica Sinica B, discusses how ALKBH3-regulated m1A of ALDOA potentiates ...

The FDA issued a complete response letter to Genentech indicating it cannot approve the company’s biologic license ...

The latest inspection comes 2 1/2 years after the agency allowed Sun Pharma to keep shipping some drugs to Americans even ...

This research indicates that Doxorubicin (Dox)-resistant TNBC cells exhibit increased glycolysis and ATP generation compared ...

One of the biggest obstacles in cancer treatment is drug resistance in cancer cells. Conventional efforts have focused on ...

The SAHPRA has assured consumers that the cancer medication sold and marketed in the country meets the relevant health ...

Doxorubicin was able to penetrate the cell membranes and bind to the nucleic material (red fluorescence), although the T-cell receptors were blocked. No doxorubicin was detected in the lysosomes.

Family doctors frequently encounter patients with vague and nonspecific symptoms, which are often attributed to common and ...

The Company's aim is to seek FDA consent to fast track the Clinical Development Program to treat Basal Cell Carcinoma (BCC) of the skin using Dissolvable Doxorubicin-containing Microneedle Arrays ...

A leading longevity doctor, Dr Valter Longo, revealed in his new book, Fasting Cancer, the diet he says may be able to cure cancer, and potentially ward it off in the first place.

Vadodara: Alembic Pharma has appointed G Krishnan as the Chief Financial Officer (CFO) and Key Managerial Personnel of the ...